**Acknowledgement**

The close collaboration since 1985 with Ingmar Jungner, the former head of CALAB laboratories in Stockholm, Sweden and the founder of the AMORIS database, is gratefully acknowledged. Many of the publications from the AMORIS study presented in this paper were also developed together with Ingar Holme, Are Aastveit, both from Oslo, Norway, Werner Kolar and Eugen Steiner, CALAB, Stockholm, Sweden, Allan Sniderman, Montreal, Canada and Niklas Hammar, Stockholm, Sweden. Their scientific knowledge and friendship is much appreciated. Much of the AMORIS work has been supported by grants from Gunnar and Ingmar Jungner Foundation for Laboratory Medicine, Stockholm, Sweden, Bure Hälsa & Sjukvård Ltd, Stockholm; and AstraZeneca, Mölndal, Sweden.

#### **Abbreviations**


